[Retracted] The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients

Table 5

The association between CTC counts and KRAS mutation status.

KRAS mutation	n	n, CTCs-Positive (%)	N, CTCs-Negative (%)
Code12	52	50 (96.15%)	2 (3.85%)
Code13	14	13 (92.86%)	1 (7.14%)
Code61	3	2 (66.67%)	1 (33.33%)
Code117	2	2 (100.00%)	0
Code146	3	2 (66.67%)	1 (33.33%)

CTCs, circulating tumor cells; KRAS, the Kirsten rat sarcoma.